Early Access Programmes
Structured support for access before routine commercial availability, where appropriate and legally permitted.
Managed Access Programmes
Programme design and coordination across eligibility, healthcare-professional engagement, supply and administration.
Therapeutic Areas
Focus areas include oncology, rare diseases, haematology, immunology and neurology.
Pharmaceutical Partnerships
Local market insight and structured access solutions for pharmaceutical and biotechnology partners.
Regulatory & Market Access
Support and coordination for market entry, documentation and healthcare stakeholder engagement.
Our purpose
Connecting innovation with patients across Africa
Medroute Access is a pharmaceutical access and market-access organisation focused on connecting pharmaceutical companies, healthcare professionals, regulators and patients through responsible, structured and compliant pathways.
About MedroutePatient Focus
Keeping appropriate patient needs at the centre of access pathways.
Integrity
Working transparently and with regulatory responsibility.
Partnership
Collaborating with global and local healthcare stakeholders.
Operational Excellence
Coordinating complex programmes with clarity and care.
Structured pathways
Early and managed access programmes
We support structured programmes through which eligible patients may gain access to innovative medicines while relevant regulatory, clinical and operational requirements are addressed.
- Programme design, eligibility workflows and administration
- Healthcare-professional and stakeholder engagement
- Regulatory, supply and documentation coordination
- Monitoring and reporting support where applicable
Regulatory and market access
Local coordination with regulatory responsibility
Our support may include NAFDAC coordination, product-registration support, regulatory documentation, market-entry strategy, importation and distribution coordination, local market intelligence and stakeholder engagement.
- Clear distinction between coordination and regulatory decisions
- Compliance-conscious documentation and workflow support
- Local-market insight for responsible market entry
Areas of focus
Therapeutic areas
These are areas of focus and do not imply that every medicine is currently available. Product-specific information remains subject to appropriate review.
Oncology
Innovative oncology medicines and supportive therapies.
Rare Diseases
Access pathways for rare and underserved conditions.
Haematology
Innovative treatments and specialist therapies.
Immunology
Advanced therapies for immune-mediated conditions.
Neurology
Innovative therapies for neurological diseases.
Other Specialities
Flexible support for additional therapeutic areas.
For pharmaceutical companies
Partner with Medroute Access
We work with pharmaceutical and biotechnology companies seeking structured market-access and patient-access solutions across Nigeria and wider African markets.
Begin an enquiry
Let’s expand access responsibly.
Whether you are a healthcare professional, pharmaceutical company, healthcare organisation, patient or representative, our team can help direct your enquiry to the appropriate pathway. Please do not submit sensitive medical information through a general enquiry form.
Request Access